Award of Phase 3 Contracts


We are pleased to announce that of the ten Contractors that successfully completed Phase 2, eight have now been awarded Specific Contracts for Phase 3 to complete testing and integration of the innovative NGS workflows. Phase 3 commenced in April 2024 and will end in May 2025. Further details can be found under Phase 3

Event Announcement: NGS for Precision Medicine and Pharmacogenomics in Cancer


The Instand NGS4P project consortium and Contractors will meet in Graz on the 9th of April 2024 to present the project and the developed Solutions at a public meeting. Two keynote speakers, Jean-Yves Blay (from Instand-NGS4P Partner CLB) and Matthias Schwab (IKP) will give talks on the challenges of precision medicine of cancer and on

Call for Service Provision on "Advancing Personalised Oncology"


The canSERV Consortium announces its first Challenge-Call on "Advancing Personalised Oncology".Cancer Researchers in, and outside the EU are invited to apply for free access to cutting-edge transnational services with an indicative overall budget of EUR 500,000. The aim of this call is to accelerate knowledge gain in personalised oncology with specific emphasis on multi-level data-based

Consortium & Contractor Meeting, 29-30.03.2023, Vienna


This year's meeting of the Instand NGS4P project consortium and contractors was held in Vienna, Austria, as a hybrid meeting combining both face-to-face and online formats. The two-day event provided a valuable platform for contractors to present their innovative prototypes to consortium members present from across Europe.In addition, the clinical project partners also had the

OECI dedicates a Special Edition Newsletter to Instand-NGS4P


Instand-NGS4P Beneficiary, OECI - the Organisation of European Cancer Institutes - has dedicated an entire Newsletter to the Instand-NGS4P project. The Newsletter describes the aims of the project, and progress made to date. This is an important dissemination tool, with the OECI Audience comprising 1300 contacts including: OECI Membership; Cancer Organisations and & relevant cancer

Event announcement: EASI-Genomics Workshop on Implementing Genomic Research Projects


This workshop addresses the key issues facing genomic research such as ethical and legal issues, privacy and data protection, data standardisation and implementation of standardised sample workflows. For further information on this event organised jointly by BBMRI-ERIC and EASI-Genomics, please visit Workshop on Implementing Genomic Research Projects | EASI-Genomics

Contract Award for PCP Phase 2 – Prototype Development


We are delighted to announce that 11 of the 14 Contractors who completed Phase 1 have been selected to enter Phase 2 and were awarded contracts on the 15th of November 2022 for development of prototypes based on their Solution Designs. Further details including the project abstracts can be found under Phase 2 – Prototype

New CEN Technical Specifications on NGS Workflow enter final technical commenting period


Analysis carried out by Instand-NGS4P´s WP7 of existing gaps in current standardization led to the proposal of 2 new Work Items for development in partnership with CEN/TC 140 “In vitro diagnostic medical devices” WG3 “Quality Management in the Medical Laboratory”:00140151 - prCEN/TS XXX In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 1: Human

Consortium Meeting, 22-23.06.2022, Florence


The Consortium Meeting of the EU-Instand NGS4P project took place in Florence, Italy on June 22-23, 2022, and was hosted by the University of Florence (Università degli Studi di Firenze | UniFI). It was the first face-to-face meeting since the 2020 Kick-off meeting in Graz due to corona pandemic restrictions.The 2 day-meeting was opened by Kurt

Contract Award for PCP Phase 1 – Solution Design


We are excited to announce that the Contract Award Notice ‘Results of the procurement procedure’ of the Instand-NGS4P Request for Tender has today been published in the Official Journal of the European Union supplement (OJ/S) and is available on the TED database under 2022/S 095-263180. The tenderers who have successfully concluded Framework Agreements and Specific

1 2 3